Progyny, Inc.

NasdaqGS PGNY

Progyny, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2024: USD -4.19 M

Progyny, Inc. Capital Expenditure is USD -4.19 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -13.76% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
  • Progyny, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -3.68 M, a -17.62% change year over year.
  • Progyny, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -3.13 M, a -94.05% change year over year.
  • Progyny, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -1.61 M, a 49.84% change year over year.
  • Progyny, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2020 was USD -3.22 M, a -275.93% change year over year.
Key data
Date Capital Expenditure Free Cash Flow Depreciation And Amortization Deferred Income Tax
Market news
Loading...
SV Wall Street
NasdaqGS: PGNY

Progyny, Inc.

CEO Mr. Peter Anevski CPA
IPO Date Oct. 25, 2019
Location United States
Headquarters 1359 Broadway
Employees 563
Sector Industrials
Industries
Description

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Similar companies

PRVA

Privia Health Group, Inc.

USD 22.85

1.38%

SLP

Simulations Plus, Inc.

USD 34.32

0.15%

TDOC

Teladoc Health, Inc.

USD 10.16

-1.74%

EVH

Evolent Health, Inc.

USD 10.45

-1.23%

NRC

National Research Corporation

USD 16.67

-0.30%

CERT

Certara, Inc.

USD 14.23

1.64%

DH

Definitive Healthcare Corp.

USD 4.86

-1.22%

PHR

Phreesia, Inc.

USD 28.46

-1.86%

HSTM

HealthStream, Inc.

USD 32.65

-0.52%

GDRX

GoodRx Holdings, Inc.

USD 4.77

-3.64%

HCAT

Health Catalyst, Inc.

USD 5.63

1.99%

VEEV

Veeva Systems Inc.

USD 233.26

-1.61%

TXG

10x Genomics, Inc.

USD 15.00

-0.53%

StockViz Staff

February 4, 2025

Any question? Send us an email